Table:
begin	end	state
1	19	non-cytoplasmic
20	38	transmembrane
39	64	cytoplasmic
65	90	transmembrane
91	95	non-cytoplasmic
96	120	transmembrane
121	144	cytoplasmic
145	164	transmembrane
165	191	non-cytoplasmic
192	213	transmembrane
214	223	cytoplasmic
224	245	transmembrane
246	250	non-cytoplasmic
251	275	transmembrane
276	314	cytoplasmic
315	336	transmembrane
337	359	non-cytoplasmic
360	381	transmembrane
382	395	cytoplasmic
396	419	transmembrane
420	424	non-cytoplasmic
425	445	transmembrane
446	481	cytoplasmic

Input:
>WP_004311272.1 NCBI__GCF_000310185.1:WP_004311272.1
MEAFANQVVDLLNGLLWGKILIWLLVGTGIYFTLRLGFIQLRHFGHTFTVLRGSRQSDAS
GISSFQALCTSLAARVGTGNIAGVAVAITLGGPGAIFWMWVIALVGMATGFAEATLAQLF
KQRDDKGQFRGGPAYYMEKGLGQRWAGTMFSIFLIIAFGFAFNSVQSNTIAGAMVGAFEL
DMGSFTLGGNEVAVAALVVGVAVTVLTAVIIFGGLRSIARFSELAVPFMAVGYLVVAVGI
LLVNLGEVPGVLAMIVKSAFGFHEAAAGGIGAAILNGFKRGLFSNEAGMGSAPNAAAAAT
PYPPHPASQGYVQMAGVFIDTILICTASAAIILLAGPVEGTGVGLVQNALTSEVGGWGKY
FLAVVVLFFAFTSIVANYFYAENCLVFIEHNHPAGLLIFRLIVLAMVMFGAIGSLPFVWN
FADVAMGLMAITNLVAILLLSGLVVKLAKDYNAQRAAGKLPTFDARAYPEIRSKLTPGIW
D

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server